BENITEC BIOPHARMA INC. (BNTC) Net income 2019–2026
BENITEC BIOPHARMA INC. (BNTC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$45.5MFY2026 · since FY2019: $2.6M → -$45.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$45.5M | -20.1% |
| FY2025 | -$37.9M | -74.3% |
| FY2024 | -$21.8M | -11.2% |
| FY2023 | -$19.6M | -7.4% |
| FY2022 | -$18.2M | -31.2% |
| FY2021 | -$13.9M | -67.8% |
| FY2020 | -$8.3M | -417.1% |
| FY2019 | $2.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BNTC financial trends
BNTC RevenueBNTC Net marginBNTC Gross profitBNTC Gross marginBNTC Operating incomeBNTC Operating marginBNTC Operating cash flowBNTC Free cash flowBNTC Capital expendituresBNTC Return on equityBNTC Stock buybacksBNTC Dividends paidBNTC Total assetsBNTC Total liabilitiesBNTC Shareholders’ equityBNTC overview →